CV_Sciences_logo2021.png
CV Sciences, Inc. Reports Second Quarter 2021 Financial Results
August 12, 2021 16:05 ET | CV Sciences, Inc.
SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV_Sciences_logo2021.png
CV Sciences, Inc. to Announce Second Quarter 2021 Results on August 12, 2021
August 05, 2021 08:00 ET | CV Sciences, Inc.
SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV_Sciences_Logo_black_tm.jpg
CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021
March 10, 2021 07:00 ET | CV Sciences, Inc.
SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV_Sciences_Logo_black_tm.jpg
CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction
December 08, 2020 07:00 ET | CV Sciences, Inc.
SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV_Sciences_Logo_black_tm.jpg
CV Sciences, Inc. Reports Second Quarter 2020 Financial Results
August 06, 2020 16:05 ET | CV Sciences, Inc.
SAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product Line
July 29, 2020 08:00 ET | CV Sciences, Inc.
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today...
CV_Sciences_Logo_black_tm.jpg
CV Sciences, Inc. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020
May 20, 2020 16:30 ET | CV Sciences, Inc.
SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today...
CV_Sciences_Logo_black_tm.jpg
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction
May 20, 2020 08:00 ET | CV Sciences, Inc.
SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV_Sciences_Logo_black_tm.jpg
CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2020
April 30, 2020 16:05 ET | CV Sciences, Inc.
SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV_Logo_Horizontal_black_300dpi (1).png
CV Sciences, Inc. to Announce Full Year 2019 Results on March 10, 2020
February 26, 2020 08:00 ET | CV Sciences, Inc.
SAN DIEGO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...